| Entry |
|
|---|
| Name |
Bucillamine (JP16/INN);
Bucilant (TN)
|
|---|
| Formula |
C7H13NO3S2
|
|---|
| Exact mass |
223.0337
|
|---|
| Mol weight |
223.313
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Interaction |
|
|---|
| Structure map |
| Antirheumatics - DMARDs and biological agents |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
442 Stimulation therapy agents
4420 Stimulation therapy agents
D01809 Bucillamine (JP16/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01C SPECIFIC ANTIRHEUMATIC AGENTS
M01CC Penicillamine and similar agents
M01CC02 Bucillamine
D01809 Bucillamine (JP16/INN)
 |
|---|
| Other DBs |
CAS: 65002-17-7 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 13
1 C1d C 17.1328 -15.5557
2 C5a C 18.3432 -14.8590
3 N1b N 19.5539 -15.5487
4 C1c C 20.7645 -14.8519
5 O5a O 18.3402 -13.4583
6 C1a C 15.9250 -14.8605
7 C1a C 16.4007 -16.7451
8 S1a S 17.8436 -16.7804
9 C1b C 21.9791 -15.5473
10 C6a C 20.7628 -13.4512
11 S1a S 23.1922 -14.8490
12 O6a O 21.9758 -12.7461
13 O6a O 19.5480 -12.7490
BOND 12
1 1 7 1
2 4 3 1 #Down
3 1 8 1
4 4 9 1
5 2 5 2
6 4 10 1
7 2 3 1
8 9 11 1
9 1 6 1
10 10 12 1
11 1 2 1
12 10 13 2
|
|---|
